亿帆医药：2025年半年度归属于上市公司股东的净利润同比增长19.91%

Group 1 - The company reported a total operating revenue of 2,635,110,083.18 yuan, representing a year-on-year growth of 0.11% [2] - The net profit attributable to shareholders of the listed company was 303,651,052.46 yuan, showing a year-on-year increase of 19.91% [2]